It’s that time of year when a man’s or a woman’s thoughts turn to eggnog, Christmas cheer and what to buy Uncle Fred. Yes, it is Xmas and as we look back on the past year, at least for investors what can we learn?
It has been a year of volatility. Much of it forced on the markets by macro factors. I am looking at you Vladimir.
We have become accustomed to great pivot points. The GFC pivot, the COVID-19 pivot but what has transpired is a W-Shaped Recovery in the markets and it looks suspiciously like we could rally into Xmas for a completely unchanged calendar year. At least on the ASX 200. Since the Easter high, it has plunged to lows at the end of the financial year, recovered, smacked again and then recovered again. Mainly as a result of the perception rightly or wrongly that the Fed will ease back on the throttle a little. A slight stutter rather than a pause.
Source: Marcus Today
The chart above looks like a ‘W’ to me and suggests a year end close back above 7350. We will see, and much hinges on the next move from the Fed. 50bps or 75bps? That is the question. Suspect the FOMC news locked in 50bps.
In the west, COVID-19 has quietly slipped into the rear-view mirror. From counting cases and lockdowns, here in Australia, life is back to the ‘new’ normal. Elsewhere too. COVID-19 is still prevalent but really not an issue for the economy. However, China has held the line on its Zero Covid policy. It had its first deaths in six months recently, and once again lockdowns and restrictions. It may be that the China bulls have got ahead of themselves. Interestingly the people on the ground have been conditioned to ‘duck and cover’ so much that even when restrictions are relaxed, they need to be dragged out of their homes. China will reopen. It is not ‘if’ but ‘when’. Judging by some of the recent protests in China, not everyone is happy to be locked down.
We have seen a conflict induced energy crisis which the OECD saying is not something we have seen since the 70s. I remember the energy crisis of the 70s. This has some way to go. Europe has been a mess on energy as its reliance on Russia has come home to bite them badly. Merkel surprisingly quiet on her legacy of Russian appeasement. There does seem to be a feeling that the peak of the crisis has passed. Gas storage has been built at a record pace, supplies procured from anywhere but Russia, and happily so far, the winter has been mild.
When we look at the winners and losers from 2022, what do they have in common? What themes can we discern from the list?
Source: Marcus Today
First off obviously, lithium and coal stocks have been the stand outs. Energy. The old and the new. A transition to clean and green is not a simple thing. There is a chasm between aspirations and reality. Seem to remember that cropping up on my school reports. The European energy crisis has highlighted that despite all our best intentions, going full on renewables is far easier said than done. COP 27 became COPOUT 27. Nobody wants to see their elderly freeze to death. The top stocks are all energy stocks. In fact, in the top 20, there is only 2 stocks that have no energy exposure. AMP (I know that is hard to believe) and CPU. Maybe PRU (although gold miners have been hit by rising energy costs) but even IPL has the energy exposure with fertiliser process linked to gas prices.
In the loser’s corner, a very mixed bag. Tech and high PE growth stocks that just didn’t. DMP for one. MP1 and BRG. Very much a chocolate box assortment of under-performance. Some have been high profile with their problems. Turns out Rock Star fund managers can be a force for good and a force for evil when it all turns to custard. Bad management is still just that, bad management.
What then has 2023 in store for us? What themes will we be looking back on next December and thinking, well that was obvious. Hindsight is a wonderful thing.
Well, if I knew that I would be a rich man. Not easy to choose one. However, sticking to a defensive, healthcare stock with corporate appeal, Ramsay Healthcare (RHC). If it can deal with its European issues, then private equity may take another look. It should also benefit from the ramp up in elective surgery and post Covid catch up.
Analysis as at 29 November 2022. This information has been provided by Marcus Today (AFSL is 473383), for WealthHub Securities Ltd ABN 83 089 718 249 AFSL No. 230704 (WealthHub Securities, we), a Market Participant under the ASIC Market Integrity Rules and a wholly owned subsidiary of National Australia Bank Limited ABN 12 004 044 937 AFSL 230686 (NAB). Whilst all reasonable care has been taken by WealthHub Securities in reviewing this material, this content does not represent the view or opinions of WealthHub Securities. Any statements as to past performance do not represent future performance. Any advice contained in the Information has been prepared by WealthHub Securities without taking into account your objectives, financial situation or needs. Before acting on any such advice, we recommend that you consider whether it is appropriate for your circumstances.